Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
This randomized, double-blind, placebo-controlled clinical phase II/III treatment trial enhances the primary characteristics of NAFLD in patients with normal and low BMI, at least in part by reducing inflammatory indices. Additional research is required to determine the precise mechanism of action of these effects.
Mofidi…